Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells.

Methods in molecular biology (Clifton, N.J.)(2021)

引用 1|浏览10
暂无评分
摘要
Patient-derived induced pluripotent stem cells (iPSCs) have recently provided a new way to model acute myeloid leukemia (AML) and other myeloid malignancies. Here, we describe methods for the generation of patient-derived iPSCs from leukemia cells and for their subsequent directed in vitro differentiation into hematopoietic cells that recapitulate features of leukemia stem cells (LSCs) and leukemic blasts.
更多
查看译文
关键词
AML,Human induced pluripotent stem cells,Reprogramming,hPSC-hematopoiesis,iPSC disease modeling
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要